It’s no-jobs Friday, thanks to the federal government shutdown robbing investors of what’s often the most closely watched piece of monthly U.S. economic data. But there are alternatives. Indeed, a ...

During the last government shutdown six years ago, the main narrative when it came to public lands was the damage caused by unsupervised visitors. Trash cans and toilets overflowed with waste.

Don’t be susceptible to cyber Fi-jackers. Google has warned Android users against “using public Wi-Fi whenever possible,” claiming that cybercriminals can use it as a Trojan horse to pilfer their bank ...

A court in West Virginia is hearing arguments Monday in a lawsuit challenging the deployment of the state National Guard to patrol the streets of Washington, D.C., as part of President Donald Trump’s ...

President Trump’s tariffs against China, where most board games are produced, have eased since earlier in the year. But the uncertainty has still roiled the American board game scene, leading to ...

ST. LOUIS – The godmother of two-year-old Bre’yeon Wells says she is heartbroken over the loss of the innocent child who she’d grown to love so much. Latoya Johnston, 42, says her connection with the ...

Baldwin Prep's cosmetology program has opened its salon to the public, with students getting hands-on experience in real-world situations. Trump 'aware' Cheney died, White House says, after history of ...

Seven schools in Fredericton, Oromocto and Moncton were closed Tuesday morning because of an “emergency situation” or “concerning messages.” Tuesday’s races were a quiet rebuke of Trump for many ...

Alessana is a researcher at the Federal University of Rondonópolis who studies how biomass ash and solid waste can restore degraded soils and reduce agricultural production costs. Her work focuses on ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...

WALTHAM, Mass., Nov. 3, 2025 /PRNewswire/ -- Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel enzyme-based products, today announced that ...